Radiation Oncology/Esophagus/RTOG Esophagus

Esophageal Cancer: RTOG OPEN TRIALS
Number Title
04-36 A Phase III Trial Evaluating The Addition Of Cetuximab To Paclitaxel, Cisplatin, And Radiation For Patients With Esophageal Cancer Who Are Treated Without Surgery

Esophageal Cancer: RTOG CLOSED TRIALS
Number Title Publication
02-46 A Phase II Study Of A Paclitaxel-Based Chemoradiotherapy Regimen With Selective Surgical Salvage For Resectable Locoregionally Advanced Carcinoma Of The Esophagus ASTRO Abstract
01-13 Non-Operative Therapy Of Local-Regional Carcinoma Of The Esophagus: A Randomized Phase II Study Of Two Paclitaxel-Based Chemoradiotherapy Regimens PMID 18574157
97-16 CALGB 9781: A Prospective Randomized Phase III Trial Comparing Trimodality Therapy (Cisplatin, 5-FU, Radiotherapy, And Surgery) To Surgery Alone For Esophageal Cancer PMID 18309943
94-05 A Phase III Intergroup Randomized Comparison Of Combined Modality Therapy For Carcinoma Of The Esophagus: High Dose Vs. Conventional Dose Radiation Therapy PMID 11870157
92-07 A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus PMID 10699886
90-12 Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus PMID 10078631
85-01 Phase III trial of combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus PMID 10235156